Chronic Coronary Syndrome Clinical Trial
Official title:
Yangxinshi Tablet Intervention for Exercise Capacity in Patients With Chronic Coronary Syndrome: Prospective, Multicentre, Randomized, Open-label, Blinded-endpoint Clinical Trial
This study is a prospective, multicentre, randomized, open-label, blinded-endpoint clinical trial to evaluate the efficacy and safety of Yangxinshi tablets in the treatment of patients with chronic coronary syndrome (CCS).
This study plans to enrol 1200 CCS patients. A central randomized control group will be set up. The experimental and control groups will be populated at a 3:1 ratio. In addition to basic medication, the experimental group will be given Yangxinshi tablets (three tablets each time, three times a day); the control group will be given basic medication only. The treatment period is 24 weeks. The primary efficacy indicator is the 6-minute walking distance (6MWD). ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT06185530 -
SECURE Trial: Stress Echocardiography With Carotid Ultrasound vs Routine CT Coronary Angiography in Chronic Coronary Syndrome for Endpoints
|
N/A | |
| Recruiting |
NCT05117866 -
Acetyl Salicylic Elimination Trial JAPAN: The ASET JAPAN Pilot Study
|
N/A | |
| Recruiting |
NCT05727982 -
Identification of Molecular Mechanisms of Coronary Instability in Homogeneous Subsets of Patients With Acute Coronary Syndromes for the Implementation of Precision Medicine
|
||
| Completed |
NCT06464276 -
Effectiveness and Tolerability of Trimetazidine 80mg Once Daily in Patients With Chronic Coronary Syndrome: The V-GOOD Study
|
||
| Recruiting |
NCT03936504 -
Efficacy and Mechanism of TCCRP in Patients With Chronic Coronary Syndrome Under Fusion Cardiac Rehabilitation Model
|
N/A | |
| Recruiting |
NCT05978089 -
Effect of Yangxinshi Tablet on Exercise Tolerance in Patients With Chronic Coronary Syndrome（MET STUDY）
|
Phase 4 | |
| Recruiting |
NCT05875311 -
Telemonitoring System for Improving Continuity of Care in Patients With Chronic Coronary Syndrome (TELSINCORC)
|
N/A | |
| Recruiting |
NCT05865600 -
Perfusion Estimation For Optimal Treatment Strategy in Chronic Coronary Syndrome
|
N/A | |
| Recruiting |
NCT06337461 -
Computational mOdelliNg of myoCardial pERfusion to Improve ouTcome Prediction Based on cOronary Artery Stenosis and Atherosclerotic Plaque Burden Assessment by Computed Tomography
|
||
| Recruiting |
NCT05640752 -
Optimal Evaluation to Reduce Imaging Testing
|
N/A | |
| Recruiting |
NCT05635994 -
Advanced Invasive Diagnosis for Patients With Chronic Coronary Syndromes Undergoing Coronary ANGIOgraphy (AID-ANGIO)
|
||
| Recruiting |
NCT05583786 -
Intracoronary ECG ST-segment Shift Remission Time During Reactive Coronary Hyperemia
|
||
| Completed |
NCT05592535 -
Outcomes With Fractional Flow Reserve in Chronic Coronary Syndrome
|
||
| Recruiting |
NCT06255678 -
Angio-based Final Functional Effect of PCI
|
||
| Recruiting |
NCT06275399 -
Comprehensive Assessment of Morphometric, Functional, Biomechanical and Biological Interactions Between Atherosclerotic Plaque and Platelets Within the Stenosed Coronary Artery
|
||
| Not yet recruiting |
NCT06186336 -
Feasibility of a Deep Learning-based Algorithm for Non-invasive Assessment of Vulnerable Coronary Plaque
|
||
| Withdrawn |
NCT04738344 -
Very Long Versus Overlapping Stents in Long Coronary Lesions
|
N/A | |
| Active, not recruiting |
NCT04135989 -
Personalized Vs. Standard Duration of Dual Antiplatelet Therapy and New-generation Polymer-Free vs- Biodegradable-Polymer DES
|
Phase 4 | |
| Recruiting |
NCT05674630 -
Ticin for the Treatment of Coronary Lesions With Drug Eluting Ballons
|
Phase 4 | |
| Recruiting |
NCT05379608 -
Intermittent Hypoxic-hyperoxic Training in Patients With Cardiovascular Pathology After COVID-19 Infection.
|
N/A |